Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
12.40
+0.16 (1.31%)
Mar 7, 2025, 4:00 PM EST - Market closed
Dyne Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 435.45 | 121.63 | 172.15 | 200.83 | 300.85 | Upgrade
|
| Short-Term Investments | 206.82 | 1.47 | 83.87 | 175.75 | 44.46 | Upgrade
|
| Cash & Short-Term Investments | 642.27 | 123.1 | 256.01 | 376.57 | 345.31 | Upgrade
|
| Cash Growth | 421.74% | -51.92% | -32.01% | 9.05% | 2259.99% | Upgrade
|
| Prepaid Expenses | 17.01 | 6.28 | 9.58 | 5.44 | 3.77 | Upgrade
|
| Restricted Cash | - | - | - | 0.38 | - | Upgrade
|
| Total Current Assets | 659.28 | 129.38 | 265.59 | 382.39 | 349.09 | Upgrade
|
| Property, Plant & Equipment | 30.01 | 33.39 | 38.41 | 40.96 | 1.95 | Upgrade
|
| Other Long-Term Assets | 1.94 | 2.32 | 2.32 | 2.31 | 2.3 | Upgrade
|
| Total Assets | 691.23 | 165.08 | 306.33 | 425.66 | 353.33 | Upgrade
|
| Accounts Payable | 6.56 | 22.94 | 5.26 | 4.03 | 3.44 | Upgrade
|
| Accrued Expenses | 30.85 | 23.44 | 18.22 | 20.74 | 7.48 | Upgrade
|
| Current Portion of Leases | 4.85 | 4.72 | 4.61 | 3.89 | - | Upgrade
|
| Other Current Liabilities | - | - | 0 | 0.06 | 0.05 | Upgrade
|
| Total Current Liabilities | 42.26 | 51.1 | 28.09 | 28.72 | 10.97 | Upgrade
|
| Long-Term Leases | 19.14 | 22.7 | 25.87 | 28.74 | - | Upgrade
|
| Total Liabilities | 61.4 | 73.79 | 53.96 | 57.47 | 10.97 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,580 | 723.8 | 649.5 | 596.93 | 421.57 | Upgrade
|
| Retained Earnings | -949.93 | -632.51 | -396.57 | -228.47 | -79.18 | Upgrade
|
| Comprehensive Income & Other | 0.01 | - | -0.57 | -0.27 | -0.03 | Upgrade
|
| Total Common Equity | 629.84 | 91.29 | 252.36 | 368.2 | 342.37 | Upgrade
|
| Shareholders' Equity | 629.84 | 91.29 | 252.36 | 368.2 | 342.37 | Upgrade
|
| Total Liabilities & Equity | 691.23 | 165.08 | 306.33 | 425.66 | 353.33 | Upgrade
|
| Total Debt | 23.99 | 27.42 | 30.48 | 32.64 | - | Upgrade
|
| Net Cash (Debt) | 618.28 | 95.69 | 225.53 | 343.94 | 345.31 | Upgrade
|
| Net Cash Growth | 546.16% | -57.57% | -34.43% | -0.40% | 2259.99% | Upgrade
|
| Net Cash Per Share | 6.57 | 1.60 | 4.34 | 6.76 | 23.99 | Upgrade
|
| Filing Date Shares Outstanding | 113.12 | 81.96 | 56.34 | 51.6 | 51.46 | Upgrade
|
| Total Common Shares Outstanding | 102.32 | 61.47 | 55.63 | 51.53 | 45.45 | Upgrade
|
| Working Capital | 617.02 | 78.28 | 237.51 | 353.67 | 338.12 | Upgrade
|
| Book Value Per Share | 6.16 | 1.49 | 4.54 | 7.15 | 7.53 | Upgrade
|
| Tangible Book Value | 629.84 | 91.29 | 252.36 | 368.2 | 342.37 | Upgrade
|
| Tangible Book Value Per Share | 6.16 | 1.49 | 4.54 | 7.15 | 7.53 | Upgrade
|
| Machinery | 11.55 | 9.64 | 8.67 | 5.2 | 2.82 | Upgrade
|
| Construction In Progress | 0.62 | 0.43 | 0.91 | 1.46 | 0.11 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.